Gut‐specific inhibition of PPARα as a novel approach of NAFLD treatment
Lanjing Zhang, Grace L. Guo – 26 May 2022
Closing the disparity gap and optimizing advanced hepatocellular carcinoma care in the hispanic community
Julio A. Gutierrez, Leticia Z. Bresnahan, Elena Rios, Priya Wanchoo, Adelfo San Valentin, Margot Embree Fisher – 26 May 2022
Sociodemographic Risk Factors for Depression in Patients With Chronic Liver Disease
Lucia Rivera‐Matos, Sarah Andrews, Sheila Eswaran – 26 May 2022
Pharmacist‐led educational interventions involving the “hidden” patient in cirrhosis—Caregivers
Zachary M. Saleh, Elliot B. Tapper – 25 May 2022
The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
Isabella Lurje, Zoltan Czigany, Sarah Eischet, Jan Bednarsch, Tom Florian Ulmer, Peter Isfort, Pavel Strnad, Christian Trautwein, Frank Tacke, Ulf Peter Neumann, Georg Lurje – 25 May 2022 – Cholangiocarcinoma (CCA) is a rare but highly aggressive malignancy of the biliary system. Although it is amenable to surgical resection in early disease, outcomes are frequently dismal. Here, we investigated the prevalence of body composition (BC) alterations and their prognostic role for surgical patients with intrahepatic (iCCA) and perihilar (pCCA) disease.
Response to Tinospora cordifolia (Giloy)‐induced liver injury during the COVID‐19 pandemic—Multicenter nationwide study from India
Geethalayam G. Gangadharan, Vinay Mahajan – 25 May 2022
Pretransplant management of the patient with severe acute‐on‐chronic liver failure
Bhupinder Kaur, Andres Cardenas, Constantine J. Karvellas – 25 May 2022
Pretransplant management of the patient with severe acute‐on‐chronic liver failure
Bhupinder Kaur, Andres Cardenas, Constantine J. Karvellas – 25 May 2022
Liver transplantation in tight junction protein‐2 deficiency associated liver disease
Jagadeesh Menon, Naresh Shanmugam, Mukul Vij, Ashwin Rammohan, Mohamed Rela – 25 May 2022
Issue Information
25 May 2022